Excited to finally share our latest study on #TranslocationRCC#PEComas@NatureComms!
We generated the first ever, murine transgenic kidney tumor models of SFPQ-TFE3 - the most common MiT/TFE gene fusion implicated in both, tRCC and PEComas (Perivascular Epitheloid neoplasms).
We describe a novel role for this fusion in regulating #mTORC1-driven lineage plasticity, with transcriptional downregulation of critical nephric lineage transcription factors like PAX8, that perfectly recapitulate human renal PEComas.
Additionally, we nominate the lysosomal V-ATPase complex as a central regulator of mTORC1 activity in tRCC, and a target-rich environment for therapeutic intervention in this deadly disease.
Grateful to all the co-authors, collaborators, reviewers, editors and funding sources who made this study possible! @adriannaamendes@LotanLab@eddieimada@MasayaBaba2@terry_watnickmd@WMarstonLinehan@PeterArgani@yasserged@rmelias2@nirmishsingla@allaf_mo@Joeyswings@KidneyCancer@kidneycan @CDMRP
https://t.co/3kcO1TWmNI
Come stop by our poster (No. 179) on the Association of Histologic Subtype, Genomic Driver Mutation, and mTORC1 Biomarker Expression in TSC1/2/MTOR-Altered Tumors! Privileged to get the opportunity to work with Dr. Lotan! @LotanLab#GUPath@TheUSCAP#USCAP2025
Joint GUPS and ISUP Expert Consultation on Intraductal Carcinoma of the #Prostate. Boston, MA USA March 22, 2025.
Thank you Dr. Rajal Shah @rajalbshah, Dr. Glen Kristiansen, @GU_Path_Society and @IntSocUropath! It’s a great moment in our field.
So proud of #GUPath! 🙏🏻
GUPS @GU_Path_Society Poster Walks return for #USCAP2025 featuring an outstanding line-up of international experts in #gupath
Especially geared to trainees, Poster Walk leaders will provide context, thematic discussion, and curated knowledge to enhance your learning experience!
Excited to Join @JHUPath Hopkins Pathology for a Career Development Session on How To Prepare for and Navigate National Meetings in advance of #USCAP2025 - thx @LotanLab for the invite!
THRILLED to announce @LotanLab 5th Director of Research @brady_urology in footsteps of Don Coffey to transform care & mentor leaders! 1st woman to hold position. Dr. Pienta to serve as Special Advisor to Provost & advance to Director Innovation and Strategy! CONGRATULATIONS!
Hopkins is recruiting 30 Bloomberg Distinguished Professors in AI + X
(X = astrophysics, cancer, neuroscience, genomics, social sciences, etc.)
https://t.co/xqH84pFcrP
22 of these 30 will be organized in clusters:
Trailblazer Award – $75,000 in partnership with @KidneyCancer was granted to Dr. Kaushal Asrani of Johns Hopkins University School of Medicine! This research project: Therapeutic Targeting of EGFR and HER2 in Translocation Renal Cell Carcinoma.
This is October 7. And you must bear witness.
The KiIIing Roads is a raw documentary of that Black Saturday — with about 50% of never-before-seen-footage.
Yes. This will punch you in your heart — over and over.
The filmmaker Igal Hecht has made it free for all.
Please share.
Excited to share our joint review with @NicolaAlesi @LisaHenske@LotanLab on the ever-expanding role of the MiT/TFE factors as upstream activators of mTORC1 and drivers of renal tumorigenesis #TSC#BHD#tRCC#TFEopathies#mTOR
Hard to imagine a future without AI pathology:
- outperforms high-quality pathologists
- provides the % of Gleason pattern 3, 4, and 5
Predicting prostate cancer grade reclassification on active surveillance using a deep Learning-Based grading algorithm https://t.co/sHlZYsl10q
Join the #ISUP “Consensus Conference on GU Precursor Lesions,” open to all in pathology, urology, and oncology. #ISUPItaly2024 🇮🇹
Complete the pre-meeting survey from all 5️⃣ working groups. Your input matters!
🔗: https://t.co/g0jS9RVWoo
🗳️ Voting Period Ends: June 30
WH spokesperson Andrew Bates responds to this hearing yesterday:
"It’s unbelievable that this needs to be said: calls for genocide are monstrous and antithetical to everything we represent as a country."
@GladellPaner@drmehrarohit We have a new mouse model of SFPQ-TFE3 carcinoma with very similar bi-phasic pattern—would be interested to know fusion partner in this case!